Skip to main content

Table 3 Prediction of outcomes with SUVmax, TMTV and TLG

From: Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL)

 

Progression-free survival

Overall survival

SUVmax

TMTV

TLG

SUVmax

TMTV

TLG

Se (%)

83.0

72.3

74.5

83.0

73.9

76.1

Sp (%)

37.8

81.1

62.2

39.5

81.6

63.2

Acc (%)

63.1

76.2

69.0

64.3

77.4

70.2

PPV (%)

62.9

82.9

71.4

62.9

82.9

71.4

NPV (%)

63.6

69.8

65.7

65.2

72.1

68.6

  1. Se sensitivity, Sp specificity, Acc accuracy, PPV positive predictive value, NPV negative predictive value, SUVmax maximum standardized uptake value, TMTV total metabolic tumor volume, TLG total lesion glycolysis